Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/10/25 13:52 | 12/9/25 | ADVM | Health | BioPrd | Biological Products, (No Diag | Fischer Laurent | CA | DO | CEO,P,Di | 2 | M.dm | 1,184 | 4.25 | 0 | 279 | 202 | D | |||||||||||||||
12/10/25 13:41 | 12/9/25 | ADVM | Health | BioPrd | Biological Products, (No Diag | Rubinstein Linda M | CA | O | CFO | 1 | M.d | 205 | 4.20 | 0 | 49 | 0 | D | |||||||||||||||
12/8/25 21:45 | 12/5/25 | ADVM | Health | BioPrd | Biological Products, (No Diag | Soparkar Peter | CA | O | COO | 1 | P | 211 | 4.22 | 0 | 50 | 166 | 80 | D | ||||||||||||||
12/5/25 18:20 | 12/4/25 | ADVM | Health | BioPrd | Biological Products, (No Diag | Leonard Braden Michael | IN | T | 2 | S.m | -4,608 | 4.19 | 0 | -1,099 | 2,620 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |